ACADIA Pharmaceuticals, Inc. (ACAD)
26.68
-0.13
(-0.48%)
USD |
NASDAQ |
Dec 11, 16:00
26.68
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Free Cash Flow: 98.97M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals, Inc. | -82.95M |
| ADMA Biologics, Inc. | 40.61M |
| Aldeyra Therapeutics, Inc. | -40.08M |
| Amicus Therapeutics, Inc. | 9.691M |
| ANI Pharmaceuticals, Inc. | 136.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 74.29M |
| Cash from Investing (Quarterly) | -79.35M |
| Cash from Financing (Quarterly) | 9.423M |
| Free Cash Flow Per Share (Quarterly) | 0.4331 |
| Free Cash Flow to Equity (Quarterly) | 75.38M |
| Free Cash Flow to Firm (Quarterly) | 73.90M |
| Free Cash Flow Yield | 2.20% |